Literature DB >> 31539696

Associations between depressive symptoms, cigarette smoking, and cardiovascular health: Longitudinal results from CARDIA.

Allison J Carroll1, Mark D Huffman2, Lihui Zhao3, David R Jacobs4, Jesse C Stewart5, Catarina I Kiefe6, Wendy Brunner7, Kiang Liu3, Brian Hitsman3.   

Abstract

INTRODUCTION: Depression is associated with increased risk of incident and recurrent cardiovascular disease, while the association between depression and cardiovascular health (CVH) remains unknown. Because the natural course of depression varies widely, different patterns of depression, as well as co-occurring factors such as cigarette smoking, may influence this relationship. We examined potential interactions between longitudinal patterns of depression and smoking with CVH.
METHODS: Using data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, we modeled trajectories of depression (Center for Epidemiologic Studies Depression scale scores; Years 5, 10, 15, 20) and smoking (cigarettes/day; Years 0, 2, 5, 7, 10, 15, 20). We calculated a modified American Heart Association (AHA) CVH Score (weight, blood glucose, cholesterol, blood pressure, physical activity, and diet; Year 20); higher scores indicate better CVH. Generalized linear models evaluated associations between depression trajectories, smoking trajectories, and their interaction with CVH Score.
RESULTS: The depression trajectory x smoking trajectory interaction was not associated with CVH Score, but main effects of depression trajectory (p < .001) and smoking trajectory (p < .001) were observed. Participants with patterns of subthreshold depression (β = -0.26, SE=0.08), increasing depression (β = -0.51 SE = 0.14), and high depression (β = -0.65, SE = 0.32) had lower CVH Scores than those without depression. Compared to never smokers, participants who quit smoking had higher CVH Scores (β = 0.38, SE = 0.11), while participants with the greatest smoking exposure had lower CVH Scores (β = -0.49, SE = 0.22). LIMITATIONS: CVH Scores were adapted from the AHA guidelines based on the available CARDIA data.
CONCLUSIONS: Deleterious depression and smoking trajectories are independently but not synergistically associated with worse CVH.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular health; Depression; Health risk behaviors; Prospective study; Smoking; Trajectory modeling

Mesh:

Substances:

Year:  2019        PMID: 31539696      PMCID: PMC6931258          DOI: 10.1016/j.jad.2019.09.049

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   6.533


  58 in total

1.  Depression is a risk factor for incident coronary heart disease in women: An 18-year longitudinal study.

Authors:  Adrienne O'Neil; Aaron J Fisher; Katherine J Kibbey; Felice N Jacka; Mark A Kotowicz; Lana J Williams; Amanda L Stuart; Michael Berk; Paul A Lewandowski; Craig B Taylor; Julie A Pasco
Journal:  J Affect Disord       Date:  2016-02-16       Impact factor: 4.839

2.  Depressive symptom trajectories and physical health: Persistence of problems from adolescence to young adulthood.

Authors:  Megan E Ames; Bonnie J Leadbeater
Journal:  J Affect Disord       Date:  2018-07-20       Impact factor: 4.839

3.  Poorer cardiovascular health is associated with psychiatric comorbidity: results from the ELSA-Brasil Study.

Authors:  Claudia Szlejf; Claudia K Suemoto; Itamar S Santos; Andre R Brunoni; Maria Angélica Nunes; Maria Carmen Viana; Sandhi Maria Barreto; Paulo A Lotufo; Isabela M Benseñor
Journal:  Int J Cardiol       Date:  2018-06-12       Impact factor: 4.164

4.  Psychiatric diagnoses among quitters versus continuing smokers 3 years after their quit day.

Authors:  Megan E Piper; Matthew Rodock; Jessica W Cook; Tanya R Schlam; Michael C Fiore; Timothy B Baker
Journal:  Drug Alcohol Depend       Date:  2012-09-17       Impact factor: 4.492

5.  Depression and smoking in the U.S. household population aged 20 and over, 2005-2008.

Authors:  Laura A Pratt; Debra J Brody
Journal:  NCHS Data Brief       Date:  2010-04

6.  Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies.

Authors:  Amanda Nicholson; Hannah Kuper; Harry Hemingway
Journal:  Eur Heart J       Date:  2006-11-02       Impact factor: 29.983

Review 7.  Depression and the risk for cardiovascular diseases: systematic review and meta analysis.

Authors:  Koen Van der Kooy; Hein van Hout; Harm Marwijk; Haan Marten; Coen Stehouwer; Aartjan Beekman
Journal:  Int J Geriatr Psychiatry       Date:  2007-07       Impact factor: 3.485

8.  Risk of incident cardiovascular events amongst individuals with anxiety and depression: A prospective cohort study in the east London primary care database.

Authors:  R Mathur; M Pérez-Pinar; Q Foguet-Boreu; S Ayis; L Ayerbe
Journal:  J Affect Disord       Date:  2016-07-19       Impact factor: 4.839

9.  Association of the Interaction Between Smoking and Depressive Symptom Clusters With Coronary Artery Calcification: The CARDIA Study.

Authors:  Allison J Carroll; Reto Auer; Laura A Colangelo; Mercedes R Carnethon; David R Jacobs; Jesse C Stewart; Rachel Widome; John Jeffrey Carr; Kiang Liu; Brian Hitsman
Journal:  J Dual Diagn       Date:  2017-01-27

Review 10.  Psychosocial Factors in Diabetes and Cardiovascular Risk.

Authors:  Ruth A Hackett; Andrew Steptoe
Journal:  Curr Cardiol Rep       Date:  2016-10       Impact factor: 2.931

View more
  2 in total

1.  Increased Levels of Serum Glycosylated Hemoglobin are Associated with Depressive Symptoms in a Population with Cancer (≥49 Years): An Antidepressant-Stratified Analysis.

Authors:  Ying Huang; Yilin Xu; Anwen Liu
Journal:  Clin Interv Aging       Date:  2021-02-02       Impact factor: 4.458

2.  Serum Human Epididymal Protein 4 is Associated with Depressive Symptoms in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Yan Shu; Wei Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.